Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14788952 | 0.86 | MMP9 (0.50) | MMP9NR1I2CYP3A4GABRA1GABRG2 | |
| Methohexital SCHEMBL80729 | 0.80 | MMP9 (0.42) | MMP9NR1I2CYP3A4GABRA1GABRG2 | |
| Methohexital SCHEMBL19420179 | 0.80 | MMP9 (0.42) | MMP9NR1I2CYP3A4GABRA1GABRG2 | |
| Methohexital SCHEMBL20980055 | 0.80 | MMP9 (0.42) | MMP9NR1I2CYP3A4GABRA1GABRG2 | |
| Methohexital SCHEMBL11111822 | 0.80 | MMP9 (0.42) | MMP9NR1I2CYP3A4GABRA1GABRG2 | |
| Methohexital SCHEMBL80730 | 0.80 | MMP9 (0.42) | MMP9NR1I2CYP3A4GABRA1GABRG2 | |
| Methohexital SCHEMBL5115660 | 0.79 | MMP9 (0.41) | MMP9NR1I2CYP3A4GABRA1GABRG2 | |
| Aprobarbital SCHEMBL78101 | 0.77 | MMP9 (0.67) | MMP9NR1I2CYP3A4GABRB3GABRB2 | |
| Aprobarbital SCHEMBL21807710 | 0.75 | MMP9 (0.65) | MMP9NR1I2CYP3A4GABRB3GABRB2 | |
| SCHEMBL10582779 | 0.75 | MMP9 (0.51) | MMP9NR1I2CYP3A4GABRB3GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5288 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240041935-A1 | PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS | CREATIVE MEDICAL TECHNOLOGIES, INC. (US) | 2024-02-08 | — | — | US | claimed |
| EP-4034087-A1 | LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS | DDS Research Inc. (CA) | 2022-08-03 | — | — | EP | claimed |
| US-20220218611-A1 | LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS | DDS RESEARCH INC. (CA) | 2022-07-14 | — | — | US | claimed |
| WO-2021056106-A1 | LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS | DDS RESEARCH INC. (CA) | 2021-04-01 | — | — | WO | claimed |
| US-20200323883-A1 | METHODS FOR TREATING AND PREVENTING VIRAL INFECTIONS | ENTERIN, INC. (US) | 2020-10-15 | — | — | US | claimed |
| EP-3646865-A1 | MEDICINE | Kowa Company, Ltd. (JP) | 2020-05-06 | — | — | EP | claimed |
| US-20200113873-A1 | MEDICAMENT | KOWA COMPANY, LTD. (JP) | 2020-04-16 | — | — | US | claimed |
| US-10478444-B2 | Methods and compositions for treating and preventing viral infections | ENTERIN, INC. (US) | 2019-11-19 | — | — | US | claimed |
| US-20180133230-A1 | METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING VIRAL INFECTIONS | ENTERIN LABORATORIES, INC. (US) | 2018-05-17 | — | — | US | claimed |
| US-9770514-B2 | Tamper-resistant pharmaceutical dosage forms | ExxPharma Therapeutics LLC (US) | 2017-09-26 | — | — | US | claimed |
| EP-0792371-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-09-03 | — | — | EP | claimed |
| EP-0786999-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-08-06 | — | — | EP | claimed |
| WO-1997009973-A2 | PERIPHERALLY ACTIVE ANTI-HYPERALGESIC OPIATES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-03-20 | — | — | WO | claimed |
| EP-0759750-A1 | COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | SHAPIRO, Howard, K. (US) | 1997-03-05 | — | — | EP | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1995031194-A1 | COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | SHAPIRO HOWARD K (US) | 1995-11-23 | — | — | WO | claimed |
| EP-0650361-A1 | COMPOSITIONS FOR THE TREATMENT OF ARTHRITIS CONTAINING PHOSPHONATES AND NSAIDS | PROCTER & GAMBLE PHARMACEUTICALS, INC. (US) | 1995-05-03 | — | — | EP | claimed |
| WO-1994000130-A1 | COMPOSITIONS FOR THE TREATMENT OF ARTHRITIS CONTAINING PHOSPHONATES AND NSAIDS | PROCTER & GAMBLE PHARMACEUTICALS, INC. (US) | 1994-01-06 | — | — | WO | claimed |